Jennifer P Morton

21PUBLICATIONS
208CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 07, 2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

|Jun 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer.

|Apr 24, 2026
βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer.

|Apr 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

|Mar 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.

Cecilia R Chambers, Supitchaya Watakul, Peter Schofield

|Oct 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.

Sigrid K Fey, Arafath K Najumudeen, Dale M Watt

Pageof 4

Frequent Collaborators

7 joint publications

Owen J Sansom

6 joint publications

Anthony J Gill

6 joint publications

David Herrmann

5 joint publications

Sean C Warren